Skip to main content
Fortis Malar Hospitals Limited logo

Fortis Malar Hospitals Limited — Investor Relations & Filings

Ticker · 523696 ISIN · INE842B01015 LEI · 335800J3QMY9M538PH34 BSE.NS Human health and social work activities
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country IN India
Listing BSE.NS 523696

About Fortis Malar Hospitals Limited

https://www.fortishealthcare.com

Fortis Malar Hospitals Limited is a multi-specialty medical facility providing comprehensive clinical services across numerous disciplines. The institution is widely recognized for its expertise in cardiology and cardiac surgery, specifically in the field of heart transplantation and advanced cardiac care. Its service portfolio encompasses a broad range of specialties, including nephrology, neurology, orthopedics, gastroenterology, and pediatrics. Equipped with advanced diagnostic infrastructure and specialized intensive care units, the hospital focuses on delivering tertiary care and complex surgical interventions. The facility caters to a broad demographic, including domestic and international patients requiring specialized medical treatment. By implementing standardized clinical protocols, the hospital maintains a focus on patient safety and clinical excellence within its multi-disciplinary healthcare environment.

Recent filings

Filing Released Lang Actions
Relevant disclosures attached.
Regulatory Filings Classification · 79% confidence The document is a compliance letter from Fortis Malar Hospitals to the BSE under SEBI Regulation 47, enclosing newspaper advertisements of the company’s audited financial results. It is not the full financial report nor earnings highlights, but a regulatory announcement providing copies of published ads. It therefore falls under general regulatory filings (fallback category) rather than being the report itself or a formal report publication notice of a new report. Thus, it should be classified as RNS (Regulatory Filings).
2026-05-19 English
Relevant disclosures attached
Regulatory Filings Classification · 80% confidence The document is a formal SEBI‐Listing‐Regulations filing notifying the BSE of the board meeting outcome. It encloses audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with the statutory auditor’s report and policy updates. It is neither a full annual report (10-K), nor a simple earnings summary (ER), nor solely an auditor’s report (AR), nor a management change notice (MANG). It is a mandatory regulatory announcement under Indian listing rules, making it a general Regulatory Filing.
2026-05-18 English
Relevant disclosures attached
Regulatory Filings Classification · 80% confidence The document is a stock exchange filing under SEBI (Listing Obligations) Regulations conveying the outcome of a Board meeting, including approval of audited financial results and related disclosures. It is a regulatory announcement rather than the full Annual Report itself (10-K) and is not a management change or dividend notice, but falls into the catch‐all category for compliance/regulatory disclosures to the exchange. Therefore, it is classified as a Regulatory Filing (RNS).
2026-05-18 English
Relevant disclosures attached
Audit Report / Information Classification · 85% confidence The document is a SEBI Listing Regulations 30 disclosure dated May 18, 2026 announcing the outcome of the Board meeting where the standalone and consolidated audited financial results for the year ended March 31, 2026 were approved. It then attaches the full Independent Auditor’s Report issued by B S R & Co. LLP, complete with audit opinion, basis for opinion, emphasis of matter, management responsibilities, and auditor responsibilities. This is not an integrated Annual Report (10-K) nor a mere brief earnings release; rather, it primarily contains the standalone audit report on the financial results. Therefore it aligns with the “Audit Report / Information” category.
2026-05-18 English
relevant disclosures attached
Audit Report / Information Classification · 85% confidence The filing is a formal SEBI Listing Regulations compliant letter conveying the outcome of a Board meeting, including the approval of audited standalone and consolidated financial results and the unmodified independent auditor’s report. It is not a full Annual Report (10-K) or mere earnings highlights, but rather the standalone Auditor’s Report on the financial results. Therefore it best fits the Audit Report / Information category (AR).
2026-05-18 English
Fortis Malar Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Regulatory Filings Classification · 74% confidence The document is a notice under Regulation 29 of SEBI LODR notifying the stock exchange of an upcoming Board meeting to approve audited financial results and the trading window closure. It does not itself contain financial results or management changes, nor is it the report itself. It is a regulatory compliance announcement without substantive data. Therefore it falls under the fallback category for miscellaneous regulatory disclosures: Regulatory Filings (RNS).
2026-05-11 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.